Literature DB >> 12943535

Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea.

Aglaia Pappa1, Tia Estey, Rizwan Manzer, Donald Brown, Vasilis Vasiliou.   

Abstract

ALDH3A1 (aldehyde dehydrogenase 3A1) is expressed at high concentrations in the mammalian cornea and it is believed that it protects this vital tissue and the rest of the eye against UV-light-induced damage. The precise biological function(s) and cellular distribution of ALDH3A1 in the corneal tissue remain to be elucidated. Among the hypotheses proposed for ALDH3A1 function in cornea is detoxification of aldehydes formed during UV-induced lipid peroxidation. To investigate in detail the biochemical properties and distribution of this protein in the human cornea, we expressed human ALDH3A1 in Sf9 insect cells using a baculovirus vector and raised monoclonal antibodies against ALDH3A1. Recombinant ALDH3A1 protein was purified to homogeneity with a single-step affinity chromatography method using 5'-AMP-Sepharose 4B. Human ALDH3A1 demonstrated high substrate specificity for medium-chain (6 carbons and more) saturated and unsaturated aldehydes, including 4-hydroxy-2-nonenal, which are generated by the peroxidation of cellular lipids. Short-chain aliphatic aldehydes, such as acetaldehyde, propionaldehyde and malondialdehyde, were found to be very poor substrates for human ALDH3A1. In addition, ALDH3A1 metabolized glyceraldehyde poorly and did not metabolize glucose 6-phosphate, 6-phosphoglucono-delta-lactone and 6-phosphogluconate at all, suggesting that this enzyme is not involved in either glycolysis or the pentose phosphate pathway. Immunohistochemistry in human corneas, using the monoclonal antibodies described herein, revealed ALDH3A1 expression in epithelial cells and stromal keratocytes, but not in endothelial cells. Overall, these cumulative findings support the metabolic function of ALDH3A1 as a part of a corneal cellular defence mechanism against oxidative damage caused by aldehydic products of lipid peroxidation. Both recombinant human ALDH3A1 and the highly specific monoclonal antibodies described in the present paper may prove to be useful in probing biological functions of this protein in ocular tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943535      PMCID: PMC1223798          DOI: 10.1042/BJ20030810

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  Enigma of the abundant water-soluble cytoplasmic proteins of the cornea: the "refracton" hypothesis.

Authors:  J Piatigorsky
Journal:  Cornea       Date:  2001-11       Impact factor: 2.651

2.  Transketolase gene expression in the cornea is influenced by environmental factors and developmentally controlled events.

Authors:  C M Sax; W T Kays; C Salamon; M M Chervenak; Y S Xu; J Piatigorsky
Journal:  Cornea       Date:  2000-11       Impact factor: 2.651

3.  Structure-activity relationships for growth inhibition and induction of apoptosis by 4-hydroxy-2-nonenal in raw 264.7 cells.

Authors:  R L Haynes; L Szweda; K Pickin; M E Welker; A J Townsend
Journal:  Mol Pharmacol       Date:  2000-10       Impact factor: 4.436

4.  Novel ABA- and dehydration-inducible aldehyde dehydrogenase genes isolated from the resurrection plant Craterostigma plantagineum and Arabidopsis thaliana.

Authors:  H H Kirch; A Nair; D Bartels
Journal:  Plant J       Date:  2001-12       Impact factor: 6.417

5.  Transmission spectra of light to the mammalian retina.

Authors:  J Dillon; L Zheng; J C Merriam; E R Gaillard
Journal:  Photochem Photobiol       Date:  2000-02       Impact factor: 3.421

6.  Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.

Authors:  A J Townsend; S Leone-Kabler; R L Haynes; Y Wu; L Szweda; K D Bunting
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

7.  Corneal and stomach expression of aldehyde dehydrogenases: from fish to mammals.

Authors:  A Pappa; N A Sophos; V Vasiliou
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

8.  Structurally normal corneas in aldehyde dehydrogenase 3a1-deficient mice.

Authors:  David W Nees; Eric F Wawrousek; W Gerald Robison; Joram Piatigorsky
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

9.  Evidence of oxidative stress in human corneal diseases.

Authors:  Rajeev Buddi; Brian Lin; Shari R Atilano; Nadia C Zorapapel; M Cristina Kenney; Donald J Brown
Journal:  J Histochem Cytochem       Date:  2002-03       Impact factor: 2.479

10.  Aldehyde dehydrogenase class 3 expression: identification of a cornea-preferred gene promoter in transgenic mice.

Authors:  W T Kays; J Piatigorsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

View more
  57 in total

1.  Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal.

Authors:  William Black; Ying Chen; Akiko Matsumoto; David C Thompson; Natalie Lassen; Aglaia Pappa; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-03-08       Impact factor: 7.376

2.  Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.

Authors:  Cameron D Buchman; Krishna K Mahalingan; Thomas D Hurley
Journal:  Chem Biol Interact       Date:  2015-01-29       Impact factor: 5.192

3.  Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.

Authors:  Cameron D Buchman; Thomas D Hurley
Journal:  J Med Chem       Date:  2017-03-06       Impact factor: 7.446

4.  Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.

Authors:  Tatsuro Naganuma; Shuyu Takagi; Tsukasa Kanetake; Takuya Kitamura; Satoko Hattori; Tsuyoshi Miyakawa; Takayuki Sassa; Akio Kihara
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

5.  Large contiguous gene deletions in Sjögren-Larsson syndrome.

Authors:  Holly Engelstad; Gael Carney; Dana S'aulis; Janae Rise; Warren G Sanger; M Katharine Rudd; Gabriele Richard; Christopher W Carr; Omar A Abdul-Rahman; William B Rizzo
Journal:  Mol Genet Metab       Date:  2011-05-30       Impact factor: 4.797

Review 6.  Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance of transparency for vision.

Authors:  Ying Chen; David C Thompson; Vindhya Koppaka; James V Jester; Vasilis Vasiliou
Journal:  Prog Retin Eye Res       Date:  2012-10-23       Impact factor: 21.198

7.  Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes.

Authors:  Tianlin Xiao; Mohammad Shoeb; M Saeed Siddiqui; Min Zhang; Kota V Ramana; Satish K Srivastava; Vasilis Vasiliou; Naseem H Ansari
Journal:  J Toxicol Environ Health A       Date:  2009

8.  4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells.

Authors:  Dimitrios Stagos; Hongfei Zhou; David Ross; Vasilis Vasiliou
Journal:  Biochem Biophys Res Commun       Date:  2008-12-03       Impact factor: 3.575

Review 9.  Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells.

Authors:  Vasilis Vasiliou; David C Thompson; Clay Smith; Mayumi Fujita; Ying Chen
Journal:  Chem Biol Interact       Date:  2012-11-16       Impact factor: 5.192

Review 10.  Antioxidant defenses in the ocular surface.

Authors:  Ying Chen; Gaurav Mehta; Vasilis Vasiliou
Journal:  Ocul Surf       Date:  2009-10       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.